In a population-based cohort and a screening trial of individuals at high risk of ovarian cancer, both RAD51C and RAD51D were shown to be moderately susceptible to ovarian cancer, suggesting the usefulness of these genes alongside BRCA1/2 for the prediction of susceptibility to ovarian cancer [11]. This evidence concerns the gene BRCA1 and ovarian carcinoma.